Pfizer recalls two drugs in U.S. on labelling error
Tuesday, 29 March 2011, 07:24 IST
Printer Print Email Email
New Delhi: Pfizer today said its wholly-owned arm Greenstone LLC is conducting a voluntary recall in the U.S. market of two drugs, which were contract manufactured by Aurobindo Pharma due to labelling error. The recall involves Citalopram 10mg tablets (100-count bottle), used in treatment of depression and Finasteride 5mg tablets (90-count bottle) prescribed for treating prostrate enlargement. "The recall is due to the possibility that incorrect labels have been placed on the bottles by a third-party manufacturer. This is the only lot number being recalled and no other lots or markets are believed to be impacted," Pfizer said in a statement on its website. Hyderabad-based Aurobindo Pharma is the third party manufacturer of the two drugs which have been recalled by Greenstone. Reacting to the recall news, shares of Aurobindo Pharma today tanked 5.
Source: PTI
siliconindia